Sign inDemant's hearing care business growth meets expectations but 2024 hearing aid sales underwhelm
According to its tidy custom, Demant's transparency on financial reporting has been delivered fast and granular for its 2024 business. The group foresees three-to-seven percent overall organic growth for 2025, but "flattish development" in the hearing aid market.
© Demant
Denmark-based hearing health giant Demant has published its 2024 annual report, announcing revenue growth of 4% (2% organic) in 2024 "as expected", driven by strong performance in Hearing Care.
Demant covers three business areas: Hearing Care, Hearing Aids, and Diagnostics, with clear synergies between them. As a group, in 2024 Demant generated DKK 22,419 million (approx 3,023m euros) in revenue, its largest markets being Europe and North America. Total reported overall growth for the Group was 4% in 2024. The group outlook for 2025 is organic growth of 3-7%.
Strong performance in hearing care
[caption id="attachment_139574" align="alignright" width="300"]...
This content is reserved for subscribers to Audiology Worldnews
Already subscribed Log in
